Skip to main content
Premium Trial:

Request an Annual Quote

DTRA Offers $1M Prize for Software to ID Non-Host Organisms via Sequence Data


The US Government’s Defense Threat Reduction Agency is offering a $1 million award for programs that can analyze samples containing mixed segments of genetic sequences generated by next-generation sequencing instruments.

According to DTRA, these algorithms should be able to suss out the identities of each organism represented in the sample and characterize all non-host organisms.

The challenge will provide datasets from Roche 454, Illumina, Pacific Biosystems PacBio RS, and Life Technologies Ion Torrent PGM sequencers.

Submissions must include a detailed description of the proposed algorithm and how it addresses technical requirements provided in the challenge description. They should also include source code implementing the proposed algorithm as well as all dependencies, packages, databases, documentation, and information used to generate test results.

The winning entry solution must outscore the benchmark solution set by DTRA in order to receive an award.

Deadline for entry into the contest is May 31, 2013, and the winner will be announced in September Additional details are available here.

The challenge is being run by InnoCentive, a Boston, Mass. — based company that puts on challenges aimed at solving research and development problems in domains such as engineering, computer science, life science, and business among other.

Filed under

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.